1. Home
  2. TYL vs PEN Comparison

TYL vs PEN Comparison

Compare TYL & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyler Technologies Inc.

TYL

Tyler Technologies Inc.

HOLD

Current Price

$344.60

Market Cap

13.5B

Sector

Technology

ML Signal

HOLD

Logo Penumbra Inc.

PEN

Penumbra Inc.

HOLD

Current Price

$332.35

Market Cap

12.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYL
PEN
Founded
1966
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5B
12.9B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
TYL
PEN
Price
$344.60
$332.35
Analyst Decision
Buy
Buy
Analyst Count
11
17
Target Price
$474.36
$357.33
AVG Volume (30 Days)
431.8K
509.9K
Earning Date
04-29-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
19.01
1155.56
EPS
7.20
4.52
Revenue
$493,101,000.00
$1,403,665,000.00
Revenue This Year
$9.59
$14.34
Revenue Next Year
$9.70
$13.71
P/E Ratio
$46.98
$73.56
Revenue Growth
18.35
17.50
52 Week Low
$283.72
$221.26
52 Week High
$621.34
$362.41

Technical Indicators

Market Signals
Indicator
TYL
PEN
Relative Strength Index (RSI) 53.76 46.81
Support Level $341.98 $326.58
Resistance Level $365.00 $338.99
Average True Range (ATR) 9.98 2.25
MACD 1.25 0.40
Stochastic Oscillator 91.70 53.48

Price Performance

Historical Comparison
TYL
PEN

About TYL Tyler Technologies Inc.

Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.

About PEN Penumbra Inc.

Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.

Share on Social Networks: